BMO Capital Maintains Outperform on Ingevity, Raises Price Target to $70
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $64 to $70.
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $64 to $70.